Videos

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses areas of unmet need and challenges ahead in the ID development economic landscape.

Jason Tokumoto, MD, discusses the evolution of HIV treatment.

Andrea L. Cox, MD, PhD, comments on the future of HCV vaccine development efforts in light of the 2019 trial which did not prevent chronic infection.

Mark Riddle, MD, DrPH, speaks to Contagion about preventing drug resistance in people who acquire traveler's diarrhea.

Andrea L. Cox, MD, PhD, discusses the implications of discovering that an experimental vaccine was not effective at preventing chronic hepatitis C virus.

Daniel Chastain, PharmD, BCIDP, discusses how antiretroviral stewardship might practically be implemented in the context that antimicrobial stewardship as a whole is often underdeveloped.

Andrea L. Cox, MD, PhD, discusses some of the challenges in developing a vaccine for hepatitis C and details the results of a vaccine trial.

Max Brito, MD, MPH, explains the value of bringing safe, confidential, and non-stigmatizing HIV treatment to the community at IDWeek2019.

Daniel B. Chastain, PharmD, BCIDP, AAHIVP, clinical assistant professor at the University of Georgia College of Pharmacy, explains antiretroviral stewardship.

Andrea L. Cox, MD, PhD, compares the rates of hepatitis C and hepatitis B diagnoses since the start of the opioid epidemic.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains why everyone needs a flu shot and addresses skepticism toward the vaccine.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses changes in public health and society since the early 20th century in response to speculation about whether large-scale global pandemics are still possible in the 21st century.

Pamela Gorman, RN, ACRN, describes the benefits of connecting care to incarcerated people with HIV.

Pamela Gorman, RN, ACRN, describes a transitional care coordination program for incarcerated individuals with HIV returning to the community primary care setting.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, describes the current state of antimicrobial stewardship efforts.

Rasheeta Chandler, PhD, RN, APRN-BC, FNP-BC, FAANP, FAAN, explains the need to incorporate women at-risk for or living with HIV into the decision-making process if we are to end the epidemic.

Max Brito, MD, MPH, remarks on the underrepresentation of transgender women in HIV and other sexual health research.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses his journey from social media skeptic to “Twitter convert.”

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses some of the broader themes in ID over the course of 2019.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses noteworthy infectious disease papers published in 2019.

Daniel B. Chastain, PharmD, BCIDP, AAHIVP, discusses a retrospective study of errors occurring in the treatment of patients with HIV.

Jason Tokumoto, MD, discusses how occupying the role of both patient and physician can provide a human perspective on HIV care.

Brenna Hughes, MD, MSc, explains why we need more effective options for congenital CMV.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, weighs in on the role of guidelines in ID treatment.

Pamela Gorman, RN, ACRN, discusses the importance of clinics having team members who come from the community patients are being recruited from.

Jason Tokumoto, MD, discusses recent developments in HIV treatment and prevention, focusing on the impact of “U=U.”

Jason Schafer, PharmD, MPH, BCPS AQ-ID, discusses upcoming long-acting therapies for HIV.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, previews his editor-in-chief letter for the December issue.

Brenna Hughes, MD, MSc, discusses the hypothesis that CMV hyperimmune globulin could have an effect on stopping congenital infections and results of a trial.

Gregory Felzien, MD, AAHIVS, highlights “clinic champions” who help move patient care forward while facing external constraints.